002566.SZ Stock Analysis
00
Neutral
Based on Eyestock quantitative analysis, 002566.SZ`s fundamental data and valuation indicate an investment grade of Neutral at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Undervalued
Jilin Jian Yisheng Pharmaceutical Co., Ltd. engages in the research and development, production, and distribution of Chinese patent medicines. The company is headquartered in Tonghua, Jilin and currently employs 1,712 full-time employees. The company went IPO on 2011-03-18. The Company’s main products consist of Shengmai injections, Zhenyuan capsules, Xinyue capsules, Qingkailing injections and Guifu Dihuang capsules, among others. The firm's products are applied in the treatment for heart cerebrovascular diseases and detoxification. The firm also provides health care products and cosmetics. The firm distributes its products within China market.